RMTI

RMTI

USD

Rockwell Medical Inc. Common Stock

$1.230+0.020 (1.653%)

Reaalajas hind

Healthcare
Drug Manufacturers - Specialty & Generic
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$1.210

Kõrge

$1.310

Madal

$1.200

Maht

0.07M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

42.0M

Tööstusharu

Drug Manufacturers - Specialty & Generic

Riik

United States

Kauplemisstatistika

Keskmine maht

0.26M

Börs

NCM

Valuuta

USD

52 nädala vahemik

Madal $0.86Praegune $1.230Kõrge $5.15

Tehisintellekti analüüsiaruanne

Viimati uuendatud: 2. mai 2025
Tehisintellekti loodudAndmeallikas: Yahoo Finance, Bloomberg, SEC

RMTI: Rockwell Medical Inc. Common Stock - What's Going On and What Might Be Next

Stock Symbol: RMTI Generate Date: 2025-05-02 10:43:32

Alright, let's break down what's been happening with Rockwell Medical (RMTI) and see what the data might be hinting at. Think of this as chatting about the stock over coffee.

What's Been Happening? (News & Price Check)

First off, the news flow has been pretty light lately. We know the company plans to share its first-quarter results on May 12th. That's just an announcement for now, but earnings reports can definitely shake things up, sometimes for the better, sometimes not. It's a date to circle on the calendar if you're watching this stock.

The other notable piece of news came out back in late March. An analyst over at HC Wainwright & Co. kept their "Buy" rating on RMTI, which sounds good on the surface. But here's the catch: they slashed their price target from a hopeful $7 all the way down to $3. That's a pretty big cut, and it tells us that even though they still think the stock could go up, they see a much lower ceiling for it than before. That kind of move from an analyst can definitely weigh on investor sentiment.

Now, let's look at the price chart over the last few months. It hasn't been a smooth ride. Back in early February, the stock was trading around $2.00. Since then, it's been on a clear downward slide. There was a particularly sharp drop around late March, right after that analyst news came out. The price has drifted lower since then, hitting a low point around $0.86 in early April. More recently, it seems to have found a bit of a floor, bouncing around between roughly $1.00 and $1.20. As of yesterday, it closed right around $1.08.

Looking Ahead (AI & Potential Moves)

So, where does that leave us? The AI prediction model we're looking at offers a little glimmer of potential short-term upside from here. It's forecasting the price to stay flat today (0.00% change), but then tick up slightly by 2.49% tomorrow and another 3.49% the day after. It even mentions a potential target price of $1.03, which seems a bit odd given the current price is $1.08 and it predicts increases, but the overall direction it's pointing for the next couple of days is slightly positive.

Putting the news, price action, and AI prediction together, it's a bit of a mixed picture, but with some clear caution flags. The long-term price trend has been down, and that analyst target cut is a significant negative signal. However, the stock seems to have stabilized recently, and the AI is predicting a small bounce from the current level.

Given the sharp drop already and the AI's short-term forecast, the situation might suggest a 'hold' if you're already in, or perhaps a cautious look for those considering getting in, but only if you're comfortable with the risks. The analyst's lowered target can't be ignored.

If someone were thinking about potentially getting into this stock based on the recent stability and the AI's short-term positive outlook, the current price area around $1.08 could be a point of interest. It seems to be acting as a recent support level.

Thinking about managing risk is key here. If the price starts to fall again, especially breaking below recent lows, that could signal more trouble. The data suggests a potential stop-loss level around $0.97. On the flip side, if the AI prediction plays out and the stock moves up, a potential area to watch for taking some profits might be around $1.15 or so, based on the provided data's suggestion. Remember, these are just potential levels based on the analysis, not guarantees.

A Bit About the Company

Just to round things out, Rockwell Medical is a healthcare company that makes and sells products used in kidney dialysis. They're a relatively small company with a market value around $37 million and average trading volume isn't huge. Small companies like this can sometimes see bigger price swings, so that's something to keep in mind.


Important Note: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock investing involves risk, and you could lose money. Always do your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Seotud uudised

BusinessWire

Rockwell Medical to Release First Quarter 2025 Results on Monday, May 12, 2025

Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today

Vaata rohkem
Rockwell Medical to Release First Quarter 2025 Results on Monday, May 12, 2025
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Rockwell Medical, Lowers Price Target to $3

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rockwell Medical with a Buy and lowers the price target from $7 to $3.

Vaata rohkem
HC Wainwright & Co. Maintains Buy on Rockwell Medical, Lowers Price Target to $3

Tehisintellekti ennustusBeta

Tehisintellekti soovitus

Tõusev

Uuendatud kell: 4. mai 2025, 15:48

LangevNeutraalneTõusev

70.1% Kindlus

Risk ja kauplemine

Riskitase4/5
Kõrge risk
Sobib
Agressiivne
Kauplemisjuhend

Sisenemispunkt

$1.23

Võta kasum

$1.32

Peata kahjum

$1.10

Põhitegurid

DMI näitab langustrendi (ADX:12.8, +DI:22.5, -DI:25.2), mis viitab ettevaatlikkusele
Praegune hind on tugitasemele ($1.22) äärmiselt lähedal, mis viitab tugevale ostuvõimalusele
Kauplemismaht on 10.1x keskmisest (4,939), mis viitab äärmiselt tugevale ostusurvele
MACD -0.0031 on signaalijoone -0.0033 kohal, mis viitab tõusvale ristumisele

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.